METformin and FINGER Intervention to Prevent Cognitive Impairment and Disability in Older Adults at Risk for Dementia

PHASE2RecruitingINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

January 25, 2023

Primary Completion Date

February 28, 2027

Study Completion Date

June 28, 2027

Conditions
Cognitive DeclineCognitive ImpairmentDementia
Interventions
COMBINATION_PRODUCT

FINGER 2.0 multidomain lifestyle-based intervention

"Multimodal lifestyle-based precision prevention intervention, including:~* Optimized FINGER multidomain lifestyle intervention (diet, physical activity, cognitive training and cardiovascular/metabolic risk monitoring and social interaction)~* Metformin (Glucophage® XR)"

OTHER

Self-guided multidomain lifestyle intervention

Participants build their own healthy lifestyle program based on standard healthy lifestyle advice on diet, physical activity, cognitive training and cardiovascular/metabolic risk

Trial Locations (3)

FI-00271

RECRUITING

Finnish Institute of Health and Welfare - THL, Helsinki

171 64

RECRUITING

Karolinska Institutet, Solna

W6 8RP

RECRUITING

Ageing Epidemiology Research Unit, Imperial College London, London

All Listed Sponsors
collaborator

Alzheimer's Association

OTHER

collaborator

Alzheimer's Drug Discovery Foundation

OTHER

collaborator

Alzheimerfonden

UNKNOWN

collaborator

Region Stockholm

OTHER_GOV

collaborator

Merck KGaA, Darmstadt, Germany

INDUSTRY

collaborator

Finnish Institute for Health and Welfare

OTHER_GOV

collaborator

Fingers Brain Health Institute

OTHER

collaborator

Karolinska University Hospital

OTHER

collaborator

Karolinska Institutet

OTHER

lead

Imperial College London

OTHER